-
Understand and analyze the current situation and issues related to pharmaceutical consultation, and study the future functions and modalities of pharmaceutical consultation.
-
Promote the use of customer feedback (inquiries, complaints, requests, etc.) received by the Pharmaceuticals Consultation Service.
-
To improve accessibility of drug information for customers, new digital technologies will be utilized, and methods of content maintenance, construction of system infrastructure, and channels will be studied.
-
Promote the spread of "PhindMI," a common platform for providing drug information.
-
Deepen cooperation with government, related organizations, and related academic societies to share information and promote mutual understanding.
-
Study how information should be provided to patients, etc., and how to improve the scope and accessibility of such information.
-
Identify and address issues that need to be resolved in the provision of information on ethical drugs in accordance with the latest guidelines, etc.
-
Revise and review the "Guidelines for Pharmaceutical Consultation Response" based on the above to improve response capabilities.
